Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11964968 Compounds useful for inhibiting RET kinase

Patent 11964968 was granted and assigned to Eli Lilly and Company on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119649680

Patent Inventor Names

Kevin R. Condroski0

Steven W. Andrews0

Manoj Kumar0

Megan McKenney0

Thomas C. Irvin0

Michael B. Welch0

Michael J. Munchhof0

Erin D. Anderson0

...

Date of Patent

April 23, 2024

Patent Application Number

181650370

Date Filed

February 6, 2023

Patent Citations

‌

US Patent 10183928 Inhibitors of RET

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11964968 Compounds useful for inhibiting RET kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API